A review guide to oligoarticular and polyarticular juvenile idiopathic arthritis

Pediatric Annals

Volumn 41, Issue 11, 2012, Pages

  Hui Yuen, Joyce S ^a   Imundo, Lisa F ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; TOCILIZUMAB; TRIAMCINOLONE HEXACETONIDE;

ARTICLE; BONE PAIN; CHRONIC ARTHRITIS; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMORBIDITY; COMPETITIVE INHIBITION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; GAIT DISORDER; GENETIC SUSCEPTIBILITY; HUMAN; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MUSCULOSKELETAL PAIN; OSTEOPOROSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATHOGENESIS; PATIENT MONITORING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROGNOSIS; REMISSION; SLIT LAMP; UVEITIS;

ADOLESCENT; ARTHRITIS, JUVENILE; BIOLOGICAL MARKERS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); UNITED STATES;

EID: 84870026514     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20121022-09     Document Type: Article

References (31)

1. Gortmaker SL, Sappenfield W. Chronic childhood disorders: prevalence and impact. Pediatr Clin North Am. 1984;31(1):3-18.
2. Cuesta IA, Kerr K, Simpson P, Jarvis JN. Subspecialty referrals for pauciarticular juvenile rheumatoid arthritis. Arch Pediatr Adolesc Med. 2000;154(2):122-125.
3. Manners P, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol. 2002;29(7):1520-1530.
4. Sacks JJ, Helmick C, Luo YH, et al. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. Arthritis Rheum. 2007;57(8):1439-1445.
5. Hashkes PJ. Wright BM, Lauer MS, et al. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum. 2010;62(2):599-608.
6. Arkela-Kautiainen M, Haapasaarij J, Kautiainen H, et al. Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis. 2005;64(6):875-880.
7. Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol. 1997;24(9):1826-1829.
8. Mauldin J, Cameron HD, Jeanotte D, Solomon G, Jarvis JN. Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskeletal Disord. 2004;5:30-36.
9. Aggarwal A, Misra R. Juvenile chronic arthritis in India: is it different from that seen in Western countries? Rheumatol Int. 1994;14(2):53-56.
10. McGhee JL, Burks F, Sheckels JL, Jarvis JN. Identifying children with chronic arthritis based on chief complaints: absence of predictive value for musculoskeletal pain as an indicator of rheumatic disease in children. Pediatrics. 2002;110(2 Pt 1):354-359.
11. Jones OY, Spencer CH, Bowyer SL, et al. A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis. Pediatrics. 2006;117(5):e840-e844.
12. Petty R, Southwood T, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-392.
13. Eichenfield AH, Athreya BH, Doughty RA, Cebul RD. Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. Pediatrics. 1986;78(3):480-484.
14. Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child. 1997;77(4):299-304.
15. Rabinovich CE. Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update. Curr Opin Rheumatol. 2011;23(5):432-436.
16. Cassidy JT, Kivlin J, Lindsley C, et al. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006;117(5):1843-1845.
17. Angeles-Han S, Prahalad S. The genetics of juvenile idiopathic arthritis: what is new in 2010? Curr Rheumatol Rep. 2010;12(2):87-93.
18. Morbach H, Wiegering V, Richl P, et al. Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(11):3458-3466.
19. Saxena N, Aggarwal A, Misra R. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. J Rheumatol. 2005;32(7):1349-1353.
20. Beukelman T, Patkar N, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465-482.
21. Ruperto N, Nikishina I, Pachanov ED, et al. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short-and long-term efficacy and safety results. Arthritis Rheum. 2005;52(2):563-572.
22. Eberhard A, Sison MC, Gottlieb BS, Ilowite NT. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol. 2004;31(12):2507-2512.
23. Silverman E, Mouy R, Spiege L, et al. Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med. 2005;352(16):1655-1666.
24. Natter MD, Winsor JR. The Childhood Arthritis and Rheumatology Research Alliance Network Registry: demographics and characteristics of the initial one year cohort. Arthritis Rheum. 2011;63(10):S747.
25. Pham T, Bachelez H, Berthelot JM, et al. TNF-alpha antagonist therapy and safety monitoring. Joint Bone Spine. 2011;78(Suppl):15-185.
26. Ruperto N, Lovell DJ, Cuttica R, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007;56(9):3096-3106.
27. Klepper SE. Effects of an eight-week physical conditioning program on disease signs and symptoms in children with chronic arthritis. Arthritis Care Res.1999;12(1):52-60.
28. Vilca I, Munitis PG, Pistorio A, et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis. 2010;69(8):1479-1483.
29. Damasio MB, Malattia C, Martini A, Toma P. Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis. Pediatr Radiol. 2010;40(6):985-998.
30. Magni-Manzoni S, Epis O, Ravelli A, et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum. 2009;61(11):1497-1504.
31. Gardner-Medwin JM, Killeen OG, Ryder CA, Bradshaw K, Johnson K. Magnetic resonance imaging identifies features in clinically unaffected knees predicting extension of arthritis in children with monoarthritis. J Rheumatol. 2006;33(11):2337-2343.